"10.1371_journal.pone.0059776","plos one","2013-03-19T00:00:00Z","John Lok Man Law; Chao Chen; Jason Wong; Darren Hockman; Deanna M Santer; Sharon E Frey; Robert B Belshe; Takaji Wakita; Jens Bukh; Christopher T Jones; Charles M Rice; Sergio Abrignani; D Lorne Tyrrell; Michael Houghton","Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada; Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, United States of America; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan; Copenhagen Hepatitis C Program, Department of Infectious Diseases and Clinical Research Centre, Copenhagen University Hospital, Hvidovre and Department of International Health, Immunology and Microbiology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America; Istituto Nazionale Genetica Molecolare, Milan, Italy","Conceived and designed the experiments: JL CC JW DH DMS MH. Performed the experiments: JL CC JW DH DMS. Analyzed the data: JL CC JW DH DMS MH. Contributed reagents/materials/analysis tools: SEF RBB TW JB CTJ CMR SA DLT. Wrote the paper: JL DMS MH.","The recombinant gpE1/gpE2 vaccine manufactured at Novartis was provided by them. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","03","John Lok Man Law","JLML",14,TRUE,6,5,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
